New research suggests women less likely to receive support for cardiogenic shock
Research analysed differences in treatment and survival between women and men with a heart attack and cardiogenic shock
Read More
Tag: Cardiogenic
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
